Assessing patient-reported symptom burden of long-term head and neck cancer survivors at annual surveillance in survivorship clinic
Head & Neck Mar 11, 2020
Townes TG, Navuluri S, Pytynia KB, et al. - Researchers describe patient-reported symptoms of long-term head and neck cancer (HNC) using the MD Anderson Symptom Inventory Head and Neck Cancer Module (MDASI-HN) in a large cohort of HNC survivors. From an institutional survivorship database, MDASI-HN results were prospectively collected. Participants in the study were 928 patients. Data reported that 46% had oropharyngeal primary tumors and 82% had squamous cell carcinoma. It was noted that 56% of patients had ablative surgery and 81% had radiation therapy as a component of treatment. Xerostomia and dysphagia were the most severe symptoms. The authors discovered that patients treated with chemoradiation or surgery followed by radiation ± chemotherapy reported the worst symptoms whereas the patient treated with surgery plus radiation ± chemotherapy reported the worst interference. HNC survivors describe their burden of long-term symptoms and inform efforts to enhance survival care for many years.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries